Source: Arranta Bio Blog

Arranta Bio Blog Join Us! Microbiome R&D and Business Collaboration Congress: Asia | April 26-27 2023 | Tokyo, Japan

Microbiome R&D and Business Collaboration Congress: Asia, April 26-27, 2023, Tokyo, Japan We are excited to be exhibiting at the Microbiome R&D And Business Collaboration Congress: Asia taking place April 26-27, 2023 in Tokyo, Japan. Arranta and Vibalogics offer CDMO capabilities from preclinical to clinical and commercial approval for new biological modalities. Encompassing technologies based [...]The post Join Us! Microbiome R&D and Business Collaboration Congress: Asia | April 26-27 2023 | Tokyo, Japan appeared first on ArrantaBio.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Mark Bamforth's photo - Founder & CEO of Arranta Bio

Founder & CEO

Mark Bamforth

CEO Approval Rating

84/100

Read more